Syndicated Report

InCrowd Survey: NASH-Treating Physician Perspectives

May 22, 2018

See the more-recent, 2019 NASH Report

InCrowd conducted 30-minute MicroQual interviews with four physicians considered key opinion leaders on Non-alcoholic Steatohepatitis (NASH). Then used this feedback to develop a 5-minute quantitative MicroSurvey for 55 gastroentologists and hepatologists.

Research Objectives:

  • Determine physician interests in and perspectives on NASH treatments in development.

  • Gauge the prevalence of comorbid conditions that require physician management alongside NASH and understand which physician specialties are ultimately stakeholders in patient care.

Method: 5-minute MicroSurvey via InCrowd
Crowds: US Gastroenterologists, Hepatologists
Sample Size: n=55
Fielding Period: April 25-26, 2018

One key insight: physicians feel that any effective treatment for NASH will need to be a combination regimen, versus a single agent, that helps resolve liver fibrosis, reduce liver inflammation, and interrupt the storage of fat in the liver.

Download the full report now!

See the more recent, 2019 NASH Report

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.